Evidence map›Paper›PMID 25412625›Full record

ArticleJournal of leukocyte biology2015

A multifunctional peptide based on the neutrophil immune defense molecule, CAP37, has antibacterial and wound-healing properties.

Anne Kasus-Jacobi, Samaneh Noor-Mohammadi, Gina L Griffith, Heather Hinsley, Lauren Mathias, H Anne Pereira

Open access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Repair Process Impairment byFrontiers in cellular and infection microbiology · 2019
    Review
  11. Review
  12. Improvement of Learning and Memory Induced byEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  13. Review
  14. Article
  15. Article
  16. Non-antibiotic management of bacterial keratitis.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anne Kasus-JacobiDepartments of *Pharmaceutical Sciences, Pathology, and Cell Biology and Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Samaneh Noor-MohammadiDepartments of *Pharmaceutical Sciences, Pathology, and Cell Biology and Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Gina L GriffithDepartments of *Pharmaceutical Sciences, Pathology, and Cell Biology and Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Heather HinsleyDepartments of *Pharmaceutical Sciences, Pathology, and Cell Biology and Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Lauren MathiasDepartments of *Pharmaceutical Sciences, Pathology, and Cell Biology and Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
H Anne PereiraDepartments of *Pharmaceutical Sciences, Pathology, and Cell Biology and Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA anne-pereira@ouhsc.edu.
University of Oklahoma Health Sciences Center · US

Funding

P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan · 2011 to 2026
$10.5M
Molecular Basis of Immunity - Kirschtein-NRSAT32AI007633 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CUNNINGHAM, MADELEINE W. · 2001 to 2022
$4.0M
Development of an antimicrobial peptide therapeutic for Pseudomonas infectionsU01AI075391 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI PEREIRA, HELOISE ANNE · 2007 to 2011
$3.4M
CAP37 and ocular inflammationR01EY015534 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI PEREIRA, HELOISE ANNE · 2007 to 2011
$1.8M
Wound healing mechanisms modulated by novel antimicrobial PeptidesR21EY026229 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI KASUS-JACOBI, ANNE · 2016 to 2017
$407k
NEI NIH HHS 5P30EY021725NEI NIH HHS 5R01EY015534NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY015534NEI NIH HHS R21 EY026229NIAID NIH HHS 5T32AI007633NIAID NIH HHS 5U01AI075391NIAID NIH HHS T32 AI007633NIAID NIH HHS U01 AI075391
6 · The paper itself

Abstract

CAP37, a protein constitutively expressed in human neutrophils and induced in response to infection in corneal epithelial cells, plays a significant role in host defense against infection. Initially identified through its potent bactericidal activity for Gram-negative bacteria, it is now known that CAP37 regulates numerous host cell functions, including corneal epithelial cell chemotaxis. Our long-term goal is to delineate the domains of CAP37 that define these functions and synthesize bioactive peptides for therapeutic use. We report the novel finding of a multifunctional domain between aa 120 and 146. Peptide analogs 120-146 QR, 120-146 QH, 120-146 WR, and 120-146 WH were synthesized and screened for induction of corneal epithelial cell migration by use of the modified Boyden chamber assay, antibacterial activity, and LPS-binding activity. In vivo activity was demonstrated by use of mouse models of sterile and infected corneal wounds. The identity of the amino acid at position 132 (H vs. R) was important for cell migration and in vivo corneal wound healing. All analogs demonstrated antimicrobial activity. However, analogs containing a W at position 131 showed significantly greater antibacterial activity against the Gram-negative pathogen Pseudomonas aeruginosa. All analogs bound P. aeruginosa LPS. Topical administration of analog 120-146 WH, in addition to accelerating corneal wound healing, effectively cleared a corneal infection as a result of P. aeruginosa. In conclusion, we have identified a multifunctional bioactive peptide, based on CAP37, that induces cell migration, possesses antibacterial and LPS-binding activity, and is effective at healing infected and noninfected corneal wounds in vivo.

Indexed as

AnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBlood ProteinsCarrier ProteinsCell MovementCorneal InjuriesFemaleHEK293 CellsHumansMicePseudomonas aeruginosaPseudomonas InfectionsWound HealingAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAZU1 protein, humanBlood ProteinsCarrier Proteinsantimicrobial peptidecell migrationcorneal wound healingkeratitisPseudomonas

Identifiers

PMID25412625
PMCPMC4304423
OpenAlexW2065993775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.